“The Preclinical Imaging Market is estimated to grow at notable growth rate over the forecast period to reach US$ 1,287.9 Mn by 2025 owing to rise in R&D for the development of advanced molecular imaging techniques by the market players”

Precision Business Insights (PBI) in its report titled “Preclinical Imaging Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The preclinical imaging market was accounted for US$ XX in 2018 and expected to account for US$ 1,287.9 Mn by 2025. Increased prevalence of various chronic diseases such as cancer, neurological disorders, and cardiovascular disorders is a major factor surge the growth of preclinical imaging market over the forecast years, For instance, As per World Health Organization 2018 data, approximately 9.6 Mn deaths occurred due to cancer across the globe. Moreover, increase in the funding for preclinical imaging from public and private sectors, technological advancements in the preclinical imaging, and rise in demand for minimally invasive diagnostic procedures are anticipated to boost the market over the forecast years. However, high cost for the installation and operations, lack of sophisticated healthcare infrastructure in underdeveloped countries, and stringent regulatory framework are estimated to impede the preclinical imaging market over the future years.

Preclinical imaging market segmented on the basis of product type, application, end user, and region.

 

 

Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16068

 

 

Reagents and Kits Segment Expected to Dominate the Market

Based on product type, preclinical imaging market segmented into imaging modalities, reagents and kits, and others. Among all the products, reagents kits segment dominated the market in 2018 and same trend is expected over the forecast years owing to surge in number of diagnostic procedures due to rise in prevalence of cancer, neurological procedures, and other chronic diseases around the globe. Moreover, rise in R&D for the development of newer products also boost the market over the forecast years. For instance, in May 2015, MR Solutions launched a conversion kit that can transform a clinical MRI system into a preclinical scanner. Additionally, imaging modality segment burgeoning at highest growth rate owing to development in health care infrastructure in developed and developing countries and increase in the adoption of advanced imaging instruments in diagnostic centers.   

North-America, Accounts for Major Revenue Share for Preclinical Imaging Market

Precision Business Insights (PBI), preclinical imaging market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for major revenue share in 2018 owing to increased prevalnece of certain types of cancers and other chronic diseases in USA and Canada. For instance, according to National Cancer Institute 208, approximately 1,735,350 cases diagnosed with cancer in USA Moreover, rise in R&D for the development of healthcare infrastructure, presence of skilled professionals, and favorable reimbursement policies are anticipated to boost the preclinical imaging market in the North America region. Europe preclinical imaging market projected to grow at significant growth rate owing to adoption of advanced technologies, increase in healthcare expenditure, and surge in incidence of cancer in the region.

Product Approval and Launch of Advanced Technologies in Preclinical Imaging Market

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

Detailed Segmentation

By Product Type

• Imaging Modalities

• Single Photon emission computed tomography (SPECT)
• Micro Computed Tomography (Micro-CT)
• Magnetic Particle Imaging
• Magnetic Resonance Imaging (MRI)
• Optical Imaging
• X-Ray Imaging
• Positron Emission Tomography (PET)
• Ultrasound
• Others

• Reagents and Kits
• Others

By Application

• Cancer
• Neurological Disorders
• Cardiovascular Disorders
• Inflammatory Diseases
• Infectious Diseases
• Others

By End-User

• Hospitals and Clinics
• Biotech Companies
• Pharmaceutical companies
• Research institutes

Geography

• North America

• US
• Canada

• Europe

• Germany
• France
• UK
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

• Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

• Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

 

For more information: https://www.precisionbusinessinsights.com/market-reports/global-preclinical-imaging-market/

 

 

About Us:

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 

Contact Us:

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com